fluorodeoxyglucose f18 has been researched along with 2-(2-nitro-1h-imidazol-1-yl)-n-(2,2,3,3,3-pentafluoropropyl)acetamide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Eskola, O; Grénman, R; Komar, G; Lehtiö, K; Levola, H; Lindholm, P; Minn, H; Seppälä, J; Seppänen, M; Sipilä, H; Solin, O | 1 |
1 other study(ies) available for fluorodeoxyglucose f18 and 2-(2-nitro-1h-imidazol-1-yl)-n-(2,2,3,3,3-pentafluoropropyl)acetamide
Article | Year |
---|---|
Prognostic value of tumour blood flow, [¹⁸F]EF5 and [¹⁸F]FDG PET/CT imaging in patients with head and neck cancer treated with radiochemotherapy.
Topics: Adult; Aged; Chemoradiotherapy; Etanidazole; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Hydrocarbons, Fluorinated; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Survival Analysis; Tomography, X-Ray Computed; Young Adult | 2014 |